z-logo
Premium
Detection of a large spectrum of viral infections in conjunctival premalignant and malignant lesions
Author(s) -
Galati Luisa,
Combes Jean Damien,
Gupta Purnima,
Sen Rajdip,
Robitaille Alexis,
Brancaccio Rosario Nicola,
Atsou Kueshivi,
Cuenin Cyrille,
McKayChopin Sandrine,
Tornesello Maria Lina,
Buonaguro Franco Maria,
Clifford Gary,
Gheit Tarik,
Tommasino Massimo
Publication year - 2020
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.33149
Subject(s) - odds ratio , conjunctiva , medicine , confidence interval , virus , virology , human papillomavirus , viral disease , immunology
To study the interaction between HIV and other carcinogenic infections in conjunctival squamous cell carcinoma (SCC), we evaluated the presence of a broad spectrum of human viruses in conjunctiva specimens. Beta Human papillomavirus (HPV; n = 46), gamma HPV (n = 52), polyomaviruses (n = 12) and herpes viruses (n = 3) was determined in DNA extracted from 67 neoplastic and 55 non‐neoplastic conjunctival tissues of HIV‐positive and HIV negative subjects by Luminex‐based assays. Next‐generation sequencing (NGS) was also used to further characterize the presence of cutaneous HPVs. Detection of beta‐2 HPV infections was associated with the risk of neoplasia (adjusted odds ratio [aOR] 3.0; 95% confidence interval [CI] 1.3‐6.8), regardless of HIV status (HIV positive, aOR 2.6, 95% CI 0.9‐7.7; HIV negative, aOR 3.5, 95% CI 0.9‐14.4). EBV was strongly associated with the risk of neoplasia (aOR 12.0, 95% CI 4.3‐33.5; P  < .01) mainly in HIV individuals (HIV positive, aOR 57.5; 95% CI: 10.1‐327.1; HIV negative aOR 2.6; 95% CI: 0.2‐34.7). NGS allowed to identify 13 putative novel HPVs in cases and controls. Our findings suggest a role of beta HPV types and EBV, in conjunctival SCC. However, additional studies of viral expression in tumor tissue are required to confirm the causal association.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here